S&CO Inc
- SEC CIK
- 0001082461
- Latest filing
- Aug 6, 2026
NBIX holding history
Neurocrine Biosciences Inc in every 13F filed by S&CO Inc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
NBIX overviewAll 13F holders of NBIXFull Q2 2026 holdings
- Shares (Q2 2026)
- 7,000
- Value
- $1.18M
- % of portfolio
- 0.1%
- Quarters held
- 10
- Since Q1 2024
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 7,000 | $1.18M | 0.1% | 00.0% | Unchanged | Holders |
| Q1 2026 | 7,000 | $922.0K | 0.1% | 00.0% | Unchanged | Holders |
| Q4 2025 | 7,000 | $992.0K | 0.1% | 00.0% | Unchanged | Holders |
| Q3 2025 | 7,000 | $982.0K | 0.1% | 00.0% | Unchanged | Holders |
| Q2 2025 | 7,000 | $879.0K | 0.1% | +2,000+40.0% | Added | Holders |
| Q1 2025 | 5,000 | $553.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2024 | 5,000 | $682.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2024 | 5,000 | $576.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2024 | 5,000 | $688.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2024 | 5,000 | $689.0K | <0.1% | +5,000 | New | Holders |